CA
SYNH

Clearstead Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Clearstead Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-318
Closed -$28K – 1463
2021
Q3 		$28K Buy
+318
New +$28.8K ﹤0.01% 719

Other funds holding SYNH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Clearstead Advisors's SYNH Position: Q4 2021 in Review

Clearstead Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2021, closing a stake of 318 shares — an estimated $28K sold.

Clearstead Advisors first reported a position in SYNH in Q3 2021 and held it in 1 quarter. The position peaked at $28K in Q3 2021. 378 funds tracked by Wall St. Rank hold SYNH as of Q4 2021.

  • Clearstead Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
  • Clearstead Advisors sold 318 Syneos Health, Inc. Class A Common Stock shares in Q4 2021, an estimated $28K.
  • Clearstead Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2021 and held it in 1 quarter.
  • Clearstead Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $28K in Q3 2021.
  • 378 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2021.

Based on Clearstead Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.